Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, Two-arm Parallel Group, Comparative Study for Assessing the Clinical Benefit of Subcutaneous Injection of Plerixafor Plus G-CSF for Mobilization and Collection of Peripheral Hematopoietic Stem Cells in Japanese Patients With Non-Hodgkin Lymphoma
Conditions
Interventions
plerixafor GZ316455
Filgrastim
Locations
12
Japan
Investigational Site Number 392005
Chiba, Japan
Investigational Site Number 392011
Fukuoka, Japan
Investigational Site Number 392014
Fukuyama-Shi, Japan
Investigational Site Number 392010
Hamamatsu, Japan
Investigational Site Number 392006
Kamogawa-Shi, Japan
Investigational Site Number 392003
Kobe, Japan
Start Date
November 1, 2014
Primary Completion Date
March 1, 2016
Completion Date
March 1, 2016
Last Updated
March 30, 2016
NCT06337318
NCT07388563
NCT06263491
NCT05529069
NCT05139017
NCT06189391
Lead Sponsor
Genzyme, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions